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The TNM classiﬁcation of renal cell carcinoma was updated in 2009. In this new classiﬁcation system,
T3a consists of tumors with renal vein involvement and tumors with fat invasion. To assess risk factors for
recurrence, we retrospectively reviewed 89 patients with pT3aN0M0 renal cell carcinoma who underwent
radical or partial nephrectomy between 1992 and 2011. Analyzed risk factors for recurrence were age,
gender, tumor size, grade, v factor, inﬁltrative growth (INF), adjuvant interferon, surgical technic (radical or
partial), clinical T classiﬁcation, renal vein thrombus, and pathological fat invasion. The median follow-up
was 52.2 months. Five-year recurrence-free survival rate was 69.0%. Within the pT3a subcategory, the
ﬁve-year recurrence-free survival was 76.7% in patients with fat invasion only, 42.9% in patients with renal
vein thrombus only, and 28.6% in patients with the two concomitant features. On univariate analysis,
tumor size, grade, INF, clinical T classiﬁcation, and renal vein thrombus were signiﬁcantly associated with
recurrence. On multivariate analysis, INF (p＝0. 023, HR 3. 927) was an independent risk factor for
recurrence. In pT3aN0M0 renal cell carcinoma, INF signiﬁcantly affects recurrence, and patients with both
fat invasion and renal vein thrombus have worst prognosis.
(Hinyokika Kiyo 60 : 1-5, 2014)














危険因子として○1 年齢，○2 性別，○3 腫瘍径，○4 grade
（組織学的異型度），○5 v factor（静脈浸潤の有無），○6
INF（組織学的浸潤増殖様式），○7 アジュバント療法





出し，log-rank test にて有意差を検定．Cox 比例ハ
ザードモデルによる単変量および多変量解析を行っ




腫瘍径は 65.3 mm であった．組織型は淡明細胞癌が
83例，乳頭状腎細胞癌および嫌色素細胞癌がそれぞれ







Table 1. Clinical and pathological features
Variables
Patients, no 89
Age, yr±SD (range) 65.1±9.8 (45-87)
Male/Female (％) 59 (66)/30 (34)
Tumor size, mm±SD (range) 65.3±35.5 (14-200)
Histologic type (％) Clear 83 (93) /Papillary 3(3)/Chromophobe 3 (3)
Grade 1/2/3/NA (％) 10 (11)/52 (58)/26 (29)/1 (1)
INF α/β/γ/NA (％) 44 (49)/28 (32)/1 (1)/16 (18)
v ＋/−/NA (％) 48 (54)/29 (33)/12 (13)
Adjuvant IFN ＋/− (％) 44 (49)/45 (51)
Surgical technic (％)
Radical 78 (88) /Partial 11
(12)/Open 43 (48)/Laparo 46
(52)
cT 1a/1b/2a/2b/3a/4 (％) 19 (21) /32 (36) /10 (11) /1(1)/25 (28)/2 (2)
Clinically renal vein thrombus
＋/− (％) 9 (10)/80 (90)
Pathologically renal vein
thrombus ＋/− (％) 17 (19)/72 (81)
Pathologically fat invasion ＋/









全474症例中副腎への浸潤で T3a から T4 に分類さ
れた症例は認めず，腎静脈進展で T3b∼T3a に分類さ
れた症例が17例であったため，2002年版 TNM 分類で










た (Table 2) ．INF 別 の 5年非再発生存率は INFα，








(F＋V 群， 7 例）で細分類すると，腫瘍径および v
factor で患者背景に有意差を認めた (Table 3）．非再
発生存率を解析すると F群，Ⅴ群，F＋V 群の順で良
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Table 2. Univariate and multivariate cox regression analyses of pathological and clinical features of pT3aN0M0 renal
cell carcinoma to predict recurrence-free survival (*statistically signiﬁcant)
Variables
Univariate analysis Multivariate analysis
HR (95％ CI) p value HR (95％ CI) p value
Age 0.998 (0.960-1.038) 0.935 ㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱ ㌱㌱㌱㌱
Gender (M/F) 1.603 (0.678-3.794) 0.283 ㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱ ㌱㌱㌱㌱
Tumor size 1.011 (1.001-1.022) 0.023* 0.998 (0.980-1.017) 0.844
INF (α/β, γ) 5.836 (2.154-15.81) ＜0.001* 3.927 (1.209-12.750) 0.023*
Grade (G1, 2/G3) 2.643 (1.217-5.743) 0.014* 2.500 (0.822-7.604) 0.107
v factor (＋/−) 1.406 (0.504-3.919) 0.515 ㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱ ㌱㌱㌱㌱
Adjuvant IFN (＋/−) 0.517 (0.226-1.183) 0.118 ㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱ ㌱㌱㌱㌱
≦cT1b/＞cT1b 0.239 (0.104-0.549) ＜0.001* 0.872 (0.205-3.703) 0.852
Clinically renal vein thrombus (＋/−) 4.738 (1.943-11.55) ＜0.001* 1.389 (0.132-14.620) 0.785
Pathologically renal vein thrombus (＋/−) 2.909 (1.294-6.539) 0.010* 2.368 (0.229-24.530) 0.470
Pathologically fat invasion (＋/−) 1.741 (0.600-5.048) 0.308 ㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱ ㌱㌱㌱㌱
Surgical technic (radical/partial) 0.654 (0.154-2.77) 0.564 ㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱㌱ ㌱㌱㌱㌱
泌60,01,01-2
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Table 3. Clinical and pathological features in the pT3a subcategory
Variables Fat invasion only Renal vein thrombus only Both p value
Patients, no 72 10 7
Age, yr 65.4±10.3 (45-87) 62.8±6.5 (52-69) 65.1±9.5 (58-84) 0.669
Male/Female (％) 49 (68)/23 (32) 5 (50)/5 (50) 5 (71)/2 (29) 0.485
Tumor size, mm 61.2±34.5 (14-200) 73.4±33.5 (34-130) 97.0±34.4 (60-150) 0.010
Grade 1/2/3/NA (％) 10 (14)/42 (58)/20 (28)/0 (0) 0 (0)/7 (70)/2 (20)/1 (10) 0 (0)/3 (43)/4 (57)/0 (0) 0.428
INF α/β/γ/NA (％) 37 (51)/22 (31)/1 (1)/12 (17) 5 (50)/2 (20)/0 (0)/3 (30) 2 (29)/4 (57)/0 (0)/1 (14) 0.427
v ＋/−/NA (％) 29 (40)/34 (47)/9 (13) 7 (70)/0 (0)/3 (30) 7 (100)/0 (0)/0 (0) 0.003
Adjuvant IFN ＋/− (％) 33 (46)/39 (54) 6 (60)/4 (40) 5 (71)/2 (29) 0.320
Median follow-up 46.7 M (1-152) 29.6 M (0-101) 24.7 M (3-73) 0.171
泌60,01,01-3

























群， F 群，F＋V 群の順でそれぞれ50，34，28％，
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